"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Atricure Inc.","AtriCure","$3,760,000","$0","$3,760,000","2010","20100202","healthcare-related offenses","off-label or unapproved promotion of medical products","","Atricure Inc., a medical device manufacturer, agreed to pay the United States $3.76 million to resolve civil claims in connection with the promotion of its surgical ablation devices.","federal","agency action","Food and Drug Administration referral to the Justice Department","civil","","","","","","","","","","","","USA","Ohio","publicly traded","ATRC","medical equipment and supplies","medical devices","https://www.justice.gov/opa/pr/atricure-pay-us-376-million-resolve-medicare-fraud-allegations",""
